ANDA 65499, held by Eugia Pharma Specialities. Ampicillin Sodium.
As of Nov 21, 2026, ANDA 65499 (Ampicillin Sodium), held by Eugia Pharma Specialities, was first approved by FDA on Aug 17, 2010, with 4 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Ampicillin for injection is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the following conditions: Respiratory Tract Infections caused by Streptococcus pneumoniae, Staphylococcus aureus (penicillinase and nonpenicillinase-producing), H. influenzae, and Group A beta-hemolytic streptococci. Bacterial Meningitis caused by E. coli, Group B Streptococci, and other Gram-negative bacteria ( Listeria monocytogenes, N. meningitidis ). The addition of an aminoglycoside with ampicillin may increase its effectiveness against Gram-negative bacteria.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 17, 2010 | Original application | Approved | None posted |
| Ampicillin SodiumEQ 125MG BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Discontinued |
| Ampicillin SodiumEQ 250MG BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Rx |
| Ampicillin SodiumEQ 500MG BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Rx |
| Ampicillin SodiumEQ 1GM BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Rx |
| Ampicillin SodiumEQ 2GM BASE/VIAL ยท injectable;injection | Ampicillin Sodium | Rx |
| May 1, 2024 | Supplement 13Labeling ยท Standard review | Approved | None posted |
| Apr 24, 2024 | Supplement 11Labeling ยท Standard review | Approved | None posted |
| Feb 21, 2018 | Supplement 4Labeling ยท Standard review | Approved | None posted |
| Feb 21, 2018 | Supplement 7Labeling ยท Standard review | Approved | None posted |
| Aug 17, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters